Related Experiment Video
Updated: Jul 16, 2026

Transcranial Direct Current Stimulation (tDCS) for Memory Enhancement
Published on: September 18, 2021
Anticholinergic medications: use among older adults with memory problems
Rachel F Kemper1, Victoria Steiner, Barbara Hicks
1Ohio State University Medical Center, Columbia, Ohio, USA. Rachel.Kemper@osumc.edu
Many older adults with memory issues take medications that can worsen confusion. A study found 10.3% of 193 older adults used drugs with anticholinergic side effects, highlighting a need for increased awareness.
Area of Science:
- Gerontology
- Clinical Pharmacy
- Neuroscience
Background:
- Anticholinergic medications can exacerbate memory impairment and confusion in older adults.
- These side effects are particularly concerning for individuals with pre-existing memory problems.
- Identifying the prevalence of anticholinergic medication use in this vulnerable population is crucial for patient safety.
Purpose of the Study:
- To determine the frequency of over-the-counter and prescription medication use with anticholinergic side effects among older adults with memory problems.
- To assess the potential risks associated with anticholinergic drug exposure in this demographic.
Main Methods:
- Retrospective chart review of 193 older adults (over 50 years) with memory problems.
- Analysis of medications used by patients during their initial clinic visit.
- Focus on medications with known anticholinergic properties.
Main Results:
- 10.3% of the studied older adults were taking one or more medications with anticholinergic side effects.
- This indicates a significant prevalence of potentially harmful drug use in this population.
- The findings underscore the need for better medication management.
Conclusions:
- There is an ongoing need for healthcare providers and consumers to be educated about the risks of anticholinergic medications in older adults with memory issues.
- Nurses play a vital role in patient education and advocating for safer medication practices.
- Interventions aimed at reducing anticholinergic burden in older adults are warranted.
Related Concept Videos
Alzheimer's Disease: Treatment
Cholinergic Antagonists: Therapeutic Uses
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal secretions in common...
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Cholinergic Antagonists: Pharmacokinetics
